Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pharm Biomed Anal ; 54(1): 208-12, 2011 Jan 05.
Artigo em Inglês | MEDLINE | ID: mdl-20727702

RESUMO

This paper describes identification and characterization of a process-related impurity of meprobamate drug substance observed in HPLC-UV method. Forced degradation studies were carried out under acidic, basic, oxidation, light and thermal conditions to assess the nature of the impurity. The pure impurity was obtained by preparative LC isolation and analyzed by NMR and mass. Structural elucidation by spectral data and formation of this impurity were discussed in detail. The structure of the process-related impurity was established as carbamic acid-2-carbamoyloxymethyl-2-methyl-pent-3-enyl ester (olefin). Also, the relative response factor, linearity, detection limit (DL), quantitation limit (QL) and recovery were determined for meprobamate and the impurity. Good linearity was obtained for the impurity over the concentration range of 0.03-0.20% (w/w) with the coefficient of determination (r(2)) of 0.999. The DL and QL of olefin impurity were 0.0003 and 0.001% (w/w), respectively. The isolated impurity was co-injected with meprobamate sample to confirm the retention time in HPLC.


Assuntos
Alcenos/análise , Química Farmacêutica/métodos , Contaminação de Medicamentos , Meprobamato/análise , Preparações Farmacêuticas/análise , Alcenos/química , Calibragem , Técnicas de Química Analítica , Cromatografia Líquida de Alta Pressão/métodos , Cromatografia Líquida/métodos , Espectroscopia de Ressonância Magnética/métodos , Espectrometria de Massas/métodos , Meprobamato/química , Modelos Químicos , Oxigênio/química , Preparações Farmacêuticas/química , Reprodutibilidade dos Testes , Espectrofotometria Ultravioleta/métodos , Raios Ultravioleta
2.
J Pharm Biomed Anal ; 54(4): 850-4, 2011 Mar 25.
Artigo em Inglês | MEDLINE | ID: mdl-21075575

RESUMO

A new chiral purity method was developed for D-cycloserine (D-cys) by reverse phase HPLC and validated. Chiral derivatizing reagents, viz., o-phthalaldehyde and N-acetyl-L-cysteine were utilized in this method. The resultant diastereomers were resolved using Zorbax SB Phenyl HPLC column under isocratic elution. A mobile phase of 95:05 (v/v), 20mM Na(2)HPO(4) (pH 7), and acetonitrile, respectively, was used with the flow rate of 1.0 mL/min and UV detection at 335 nm. The method development with different chiral stationary phases and chiral derivatization reagents were also investigated. The stability of diastereomer derivative and influence of organic modifier and pH of the mobile phase were studied and optimized. The stability-indicating capability of the method was established by performing stress studies under acidic, basic, oxidation, light, humidity and thermal conditions. The detection and quantitation limit of L-cycloserine (L-cys) were 0.015 and 0.05% (w/w), respectively. A linear range from 0.05 to 0.30% (w/w) was obtained with the coefficient of determination (r(2)) 0.998. The recovery obtained for L-cys was between 92.9 and 100.2%. This method was applied successfully in pharmaceutical analysis to determine the content of L-cys in D-cys bulk drug.


Assuntos
Antibióticos Antituberculose/análise , Ciclosserina/análise , Contaminação de Medicamentos , Tecnologia Farmacêutica , Acetilcisteína/química , Métodos Analíticos de Preparação de Amostras , Cromatografia Líquida de Alta Pressão , Contaminação de Medicamentos/prevenção & controle , Estabilidade de Medicamentos , Concentração de Íons de Hidrogênio , Indicadores e Reagentes/química , Isomerismo , Limite de Detecção , Microquímica/métodos , Controle de Qualidade , Reprodutibilidade dos Testes , o-Ftalaldeído/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...